» Articles » PMID: 28018867

Iran Diabetes Research Roadmap (IDRR): the Study Protocol

Overview
Specialty Endocrinology
Date 2016 Dec 27
PMID 28018867
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes mellitus is a common metabolic disorder which is increasing worldwide. This study aimed to undertake a survey of the diabetes research in Iran to identify gaps and highlight strengths in order to develop a roadmap for diabetes research in Iran for the next years.

Methods: To develop a roadmap and to identify major areas of diabetes research, we carried out a systematic assessment of Iranian diabetes research publications. All obtained studies were categorized to 11 groups and each group was classified according to the "study design", "subject area", "World Health Organization (WHO) classification", and "Australian Standard Research Classifications". The number of publications per each year was calculated. Research trends in publications in each area were assessed and compared.

Conclusion: By this study, we will provide the highlighted priorities, the gaps of research and strategic mapping of each area of diabetes research that could serve as a precious guideline for national research initiatives in the field of diabetes. By a strategic map, we can achieve many advances in the all aspects of diabetes research that finally impact on the health, quality of life and well-being of diabetic patients.

Citing Articles

Epidemiology of diabetes in Iran: A scoping review of studies published during 2015-2019.

Gharishvandi F, Moheimani H, Esmaeili S, Larijani B, Tootee A, Nasli Esfahani E J Diabetes Metab Disord. 2022; 21(2):1913-1921.

PMID: 36404822 PMC: 9672154. DOI: 10.1007/s40200-022-01094-0.


The association between muscle indicators and bone mass density and related risk factors in the diabetic elderly population: Bushehr Elderly Health (BEH) Program.

Nikfarjam M, Heshmat R, Gharibzadeh S, Ostovar A, Maleki V, Moludi J J Diabetes Metab Disord. 2021; 20(2):1429-1438.

PMID: 34900794 PMC: 8630123. DOI: 10.1007/s40200-021-00881-5.


World diabetes day: celebrating two decades of Progress in combating diabetes and its complications in Iran.

Bandarian F, Larijani B J Diabetes Metab Disord. 2020; 18(2):743-745.

PMID: 31890701 PMC: 6915246. DOI: 10.1007/s40200-019-00470-7.


LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations.

Razi F, Forouzanfar K, Bandarian F, Nasli-Esfahani E J Diabetes Metab Disord. 2017; 16:43.

PMID: 29142884 PMC: 5670525. DOI: 10.1186/s40200-017-0326-2.

References
1.
Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S . Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract. 2014; 103(2):319-27. DOI: 10.1016/j.diabres.2013.12.034. View

2.
Nasli-Esfahani E, Peimani M, Rambod C, Omidvar M, Larijani B . Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran. Iran J Public Health. 2015; 43(6):713-21. PMC: 4475590. View

3.
Rohrig B, du Prel J, Wachtlin D, Blettner M . Types of study in medical research: part 3 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2009; 106(15):262-8. PMC: 2689572. DOI: 10.3238/arztebl.2009.0262. View

4.
Insel R, Deecher D, Brewer J . Juvenile Diabetes Research Foundation: mission, strategy, and priorities. Diabetes. 2011; 61(1):30-5. PMC: 3237656. DOI: 10.2337/db11-1398. View

5.
Javanbakht M, Baradaran H, Mashayekhi A, Haghdoost A, Khamseh M, Kharazmi E . Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS One. 2011; 6(10):e26864. PMC: 3204988. DOI: 10.1371/journal.pone.0026864. View